M. Pamukcuoglu, N. A. Baysal, and M. S. Pepeler, “The infection rate in new diagnosis and relapsed/refractory multiple myeloma patients who had bortezomib-based chemotherapy and relationship between development of infection and lymphocyte/monocyte ratio”, Eur Res J, vol. 7, no. 6, pp. 541–549, Nov. 2021, doi: 10.18621/eurj.855510.